Researchers from the University of Melbourne developed a new non-fibrillating form of human insulin called glycoinsulin that could prevent the formation of fibrils -- or clumps of insulin -- even at high temperature and concentration, and was said to be more stable in human serum than native insulin. Detailed in the Journal of the American Chemical Society, glycoinsulin could improve the shelf life of insulin products and significantly minimize the costs and medical waste of insulin pump infusion sets.
Researchers develop non-fibrillating human glycoinsulin
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.